Prevention of vascular dementia

被引：40

作者：

Gorelick, PB

Erkinjuntti, T

Hofman, A

Rocca, WA

Skoog, I

Winblad, B

机构：

[1] Rush Med Coll, Dept Neurol Sci, Chicago, IL 60612 USA

[2] Univ Helsinki, Dept Neurol, Memory Res Unit, FIN-00014 Helsinki, Finland

[3] Erasmus Univ, Sch Med, Dept Epidemiol & Biostat, NL-3000 DR Rotterdam, Netherlands

[4] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA

[5] Mayo Clin & Mayo Fdn, Dept Neurol, Rochester, MN 55905 USA

[6] Sahlgrenska Hosp, Dept Psychiat, Gothenburg, Sweden

[7] Karolinska Inst, Dept Geriatr Med, S-10401 Stockholm, Sweden

[8] Stockholm Gerontol Res Ctr, Stockholm, Sweden

来源：

ALZHEIMER DISEASE & ASSOCIATED DISORDERS | 1999年 / 13卷

关键词：

vascular dementia; prevention; stroke; Alzheimer disease;

D O I：

10.1097/00002093-199912003-00019

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

Stroke is an important public health problem worldwide. Those at high risk of stroke may be at high risk of cognitive impairment and dementia after stroke. Modifiable cardiovascular risk factors in midlife including hypertension, alcohol use, cigarette smoking, and certain dietary factors may be important targets for prevention of vascular causes of cognitive impairment. These same types of factors may also be associated with Alzheimer disease. Better control of cardiovascular disease risk factors might lead to delay or prevention of vascular dementia and Alzheimer disease.

引用

收藏

页码：S131 / S139

页数：9

相关论文

共 87 条

[21] Association of apolipoprotein E ε2 and vasculopathy in cerebral amyloid angiopathy [J].

Greenberg, SM ;

Vonsattel, JPG ;

Segal, AZ ;

Chiu, RI ;

Clatworthy, AE ;

Liao, A ;

Hyman, BT ;

Rebeck, GW .

NEUROLOGY, 1998, 50 (04) :961-965

[22] Low blood pressure and five-year mortality in a Stockholm cohort of the very old: Possible confounding by cognitive impairment and other factors [J].

Guo, ZC ;

Viitanen, M ;

Winblad, B .

AMERICAN JOURNAL OF PUBLIC HEALTH, 1997, 87 (04) :623-628

[23]

Guo ZC, 1997, AM J EPIDEMIOL, V145, P1106

[24]

Hachinski Vladimir, 1994, P130

[25] Diabetics do not have increased Alzheimer-type pathology compared with age-matched control subjects - A retrospective postmortem immunocytochemical and histofluorescent study [J].

Heitner, J ;

Dickson, D .

NEUROLOGY, 1997, 49 (05) :1306-1311

[26] Preexisting dementia in stroke patients - Baseline frequency, associated factors, and outcome [J].

Henon, H ;

Pasquier, F ;

Durieu, I ;

Godefroy, O ;

Lucas, C ;

Lebert, F ;

Leys, D .

STROKE, 1997, 28 (12) :2429-2436

[27] Cerebral infarcts in patients with autopsy-proven Alzheimer's disease - CERAD, part XVIII [J].

Heyman, A ;

Fillenbaum, GG ;

Welsh-Bohmer, KA ;

Gearing, M ;

Mirra, SS ;

Mohs, RC ;

Peterson, BL ;

Pieper, CF .

NEUROLOGY, 1998, 51 (01) :159-162

[28] Atherosclerosis, apolipoprotein E, and prevalence of dementia and Alzheimer's disease in the Rotterdam Study [J].

Hofman, A ;

Ott, A ;

Breteler, MMB ;

Bots, ML ;

Slooter, AJC ;

vanHarskamp, F ;

vanDuijn, CN ;

Van Broeckhoven, C ;

Grobbee, DE .

LANCET, 1997, 349 (9046) :151-154

[29] Cigarette smoking and other risk factors for silent cerebral infarction in the general population [J].

Howard, G ;

Wagenknecht, LE ;

Cai, JW ;

Cooper, L ;

Kraut, MA ;

Toole, JF .

STROKE, 1998, 29 (05) :913-917

[30] Incidence and determinants of poststroke dementia as defined by an informant interview method in a hospital-based stroke registry [J].

Inzitari, D ;

Di Carlo, A ;

Pracucci, G ;

Lamassa, M ;

Vanni, P ;

Romanelli, M ;

Spolveri, S ;

Adriani, P ;

Meucci, I ;

Landini, G ;

Ghetti, A .

STROKE, 1998, 29 (10) :2087-2093

← 1 2 3 4 5 6 7 8 9 →